Syndax Pharmaceuticals logo

Syndax Pharmaceuticals Share Price (NASDAQ: SNDX)

$16.25

0.41

(2.59%)

Last updated on

Check the interactive Syndax Pharmaceuticals Stock chart to analyse performance

Syndax Pharmaceuticals stock performance

as on August 23, 2025 at 1:29 AM IST

  • Today's Low:$15.90
    Today's High:$16.38

    Day's Volatility :2.93%

  • 52 Weeks Low:$8.58
    52 Weeks High:$22.50

    52 Weeks Volatility :61.87%

Syndax Pharmaceuticals Stock Returns

PeriodSyndax PharmaceuticalsSector (Health Care)Index (Russel 2000)
3 Months
63.65%
6.0%
0.0%
6 Months
3.7%
-5.6%
0.0%
1 Year
-22.36%
-11.1%
0.0%
3 Years
-32.74%
6.8%
-7.8%

Syndax Pharmaceuticals Key Stats

Check Syndax Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$15.84
Open
$15.9
Today's High
$16.38
Today's Low
$15.9
Market Capitalization
$1.4B
Today's Volume
$1.5M
52 Week High
$22.5
52 Week Low
$8.58
Revenue TTM
$77.9M
EBITDA
$-339.0M
Earnings Per Share (EPS)
$-3.89
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-113.22%

Stock Returns calculator for Syndax Pharmaceuticals Stock including INR - Dollar returns

The Syndax Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Syndax Pharmaceuticals investment value today

Current value as on today

₹81,956

Returns

₹18,044

(-18.04%)

Returns from Syndax Pharmaceuticals Stock

₹22,360 (-22.36%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Syndax Pharmaceuticals Stock

192%

Period: Jul 24, 2025 to Aug 23, 2025. Change in 30 Days versus previous period

Search interest for Syndax Pharmaceuticals Stock from India on INDmoney has increased by 192% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Syndax Pharmaceuticals

  • Name

    Holdings %

  • BlackRock Inc

    9.93%

  • Kynam Capital Management, LP

    9.90%

  • Goldman Sachs Group Inc

    6.74%

  • Vanguard Group Inc

    5.85%

  • Eversept Partners, LLC

    4.72%

  • Point72 Asset Management, L.P.

    4.66%

Analyst Recommendation on Syndax Pharmaceuticals Stock

Rating
Trend

Buy

    89%Buy

    10%Hold

    0%Sell

Based on 19 Wall street analysts offering stock ratings for Syndax Pharmaceuticals(by analysts ranked 0 to 5 stars)

Syndax Pharmaceuticals Share Price Target

What analysts predicted

Upside of 123.78%

Target:

$36.36

Current:

$16.25

Syndax Pharmaceuticals share price target is $36.36, a slight Upside of 123.78% compared to current price of $16.25 as per analysts' prediction.

Syndax Pharmaceuticals Stock Insights

  • Price Movement

    In the last 1 month, SNDX stock has moved up by 59.0%
  • SNDX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.6% return, outperforming this stock by 87.6%
  • SNDX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 109.5% return, outperforming this stock by 143.2%
  • Price to Sales

    ForSNDX every $1 of sales, investors are willing to pay $18.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.9 for every $1 of sales.

Syndax Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Syndax Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Syndax Pharmaceuticals Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Syndax Pharmaceuticals logo
68.74%
3.7%
-22.36%
-32.74%
-3.1%
Regeneron Pharmaceuticals, Inc. logo
4.66%
-17.37%
-50.86%
-2.39%
-3.46%
Beone Medicines Ltd logo
7.62%
21.35%
57.45%
78.28%
25.05%
Vertex Pharmaceuticals Incorporated logo
-15.87%
-17.97%
-18.14%
35.67%
45.07%
Alnylam Pharmaceuticals, Inc. logo
38.16%
82.49%
68.79%
112.36%
238.79%

About Syndax Pharmaceuticals

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
Organization
Syndax Pharmaceuticals
Employees
270
CEO
Mr. Michael A. Metzger M.B.A.
Industry
Health Technology

Key Management of Syndax Pharmaceuticals

NameTitle
Mr. Michael A. Metzger M.B.A.
CEO & Director
Mr. Keith Alan Goldan CPA
CFO, Treasurer & Chief Accounting Officer
Mr. Luke J. Albrecht J.D.
Senior VP, General Counsel & Secretary
Mr. Steven Closter
Chief Commercial Officer
Dr. Peter Ordentlich B.Sc., Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Richard A. Heyman Ph.D.
Co-Founder
Dr. Ronald M. Evans Ph.D.
Co-Founder, Advisor and Chair of Scientific Advisory Board
Dr. Michael Downes Ph.D.
Co-Founder
Sharon Klahre
Vice President of Investor Relations & Communications
Mr. Kevin McManus
Chief People Officer

Important FAQs about investing in SNDX Stock from India :

What is Syndax Pharmaceuticals share price today?

Syndax Pharmaceuticals share price today is $16.25 as on at the close of the market. Syndax Pharmaceuticals share today touched a day high of $16.38 and a low of $15.90.

What is the 52 week high and 52 week low for Syndax Pharmaceuticals share?

Syndax Pharmaceuticals share touched a 52 week high of $22.50 and a 52 week low of $8.58. Syndax Pharmaceuticals stock price today i.e. is closed at $16.25, lower by 27.78% versus the 52 week high.

How to invest in Syndax Pharmaceuticals Stock (SNDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Syndax Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Syndax Pharmaceuticals Shares that will get you 0.0923 shares as per Syndax Pharmaceuticals share price of $16.25 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Syndax Pharmaceuticals Stock (SNDX) from India?

Indian investors can start investing in Syndax Pharmaceuticals (SNDX) shares with as little as ₹87.521 or $1 (as of August 24, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Syndax Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 24, 2025). Based on Syndax Pharmaceuticals share’s latest price of $16.25 as on August 23, 2025 at 1:29 AM IST, you will get 0.6154 shares of Syndax Pharmaceuticals. Learn more about fractional shares .

What are the returns that Syndax Pharmaceuticals has given to Indian investors in the last 5 years?

Syndax Pharmaceuticals stock has given -3.1% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?